12 completed, 4 unknown, 3 terminated, 3 withdrawn. 27 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 27 | Completed 12, Unknown 4, Terminated 3, Withdrawn 3, Enrolling by invitation 2, Recruiting 2, Not yet recruiting 1 |
Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Traditional Chinese Medicine Treatment for Capecitabine-Related Hand-Foot Syndrome Twelve-Ingredient Prepared Sichuan Aconite Hand and Foot Bath, Standard Basic Nursing Interventions - Palmar and Plantar Erythema, Numbness of the Four Limbs | Early Phase 1 | Not yet recruiting | Emeishan Hospital of Traditional Chinese Medicine | 7 | 2026-10-01 | 2026-10-20 |
| Adapalene Gel for Acute Radiation-Induced Skin Injury Adapalene gel 0.1%, Biafine topical emulsion - Radiation Dermatitis | Early Phase 1 | Recruiting | Yunnan Cancer Hospital | 50 | 2026-03-01 | 2026-10-26 |
| Thera-Clean® Microbubbles System in Patients With Skin Diseases TheraClean - Epidermolysis Bullosa, Ichthyosis | Early Phase 1 | Enrolling by invitation | Northwestern University | 20 | 2026-01-13 | 2026-11-09 |
| The Effectiveness of Itraconazole Pulse Therapy vs Topical 2% Ketoconazole in the Treatment of Moderate to Severe Seborrheic Dermatitis of Scalp. Itraconazole (200 mg), Ketoconazole 2% - Seborrheic Dermatitis | Early Phase 1 | Recruiting | Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan | 80 | 2026-01-07 | 2026-07-29 |
| Comparative Efficacy of Topical Oxiconazole Cream (1%) Versus Topical Clotrimazole Cream (1%) in the Treatment of Tinea CrurisAbstract Topical Oxiconazole cream, Topical Clotrimazole cream - Tinea Cruris | Early Phase 1 | Completed | Hayat Abad Medical Complex, Peshawar | 386 | 2025-05-15 | 2026-02-27 |
| Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis Abrocitinib, Tofacitinib - Toxic Epidermal Necrolysis | Early Phase 1 | Unknown | Peng Zhang | 30 | 2023-07-05 | 2023-11-28 |
| Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis Caffeine, Metoprolol, Midazolam - Atopic Dermatitis | Early Phase 1 | Completed | Amgen | 21 | 2023-06-03 | 2025-12-23 |
| Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis GD-iExo-001, normal saline - Atopic Dermatitis | Early Phase 1 | Unknown | Peking Union Medical College Hospital | 20 | 2023-04-12 | 2023-08-01 |
| IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis Dupilumab, Photo therapy - Atopic Dermatitis | Early Phase 1 | Completed | Mayo Clinic | 7 | 2022-08-09 | 2024-02-26 |
| Cyclosporine Vs Steroids in DRESS Cyclosporine, Methylprednisolone and Prednisone - DRESS Syndrome, Drug-Induced Hypersensitivity Syndrome | Early Phase 1 | Enrolling by invitation | University of Southern California | 50 | 2021-09-27 | 2025-03-30 |
| Dilute Bleach Compresses for Radiation Dermatitis Di-Dak-Sol, White Petrolatum - Radiation Dermatitis | Early Phase 1 | Withdrawn | Dana-Farber Cancer Institute | 2021-06-09 | 2022-02-15 | |
| Characterizing Skin Microbiome Change in Atopic Dermatitis Crisaborole 2% Top Oint, Skin Microbiome Swabs - Atopic Dermatitis, Atopic Dermatitis Eczema | Early Phase 1 | Completed | University of California, Irvine | 20 | 2021-03-23 | 2024-02-02 |
| Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis Stabilised Whole Rice Bran - Dermatitis, Atopic | Early Phase 1 | Completed | RCSI & UCD Malaysia Campus | 75 | 2020-09-21 | 2023-03-29 |
| Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects Baricitinib, Placebo - Allergic Contact Dermatitis | Early Phase 1 | Completed | Wright State Physicians | 23 | 2020-09-14 | 2023-12-05 |
| Glutamine Supplementation in People With Immune Dysregulation L-glutamine - Eczema, MTOROC1 Signaling | Early Phase 1 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-03-12 | 2020-03-16 | |
| Treatment of Nighttime Pruritus in Atopic Dermatitis Melatonin, Diphenhydramine, Placebos - Atopic Dermatitis | Early Phase 1 | Withdrawn | University of Nebraska | 2019-02-02 | 2024-09-03 | |
| Pro-Resolving Mediators in Acute Inflammation in Humans Lovaza, Cantharone, Phlebotomy - Inflammation; Skin, Resolution | Early Phase 1 | Completed | Brigham and Women's Hospital | 19 | 2018-07-02 | 2022-05-26 |
| Skin Barrier Dysfunction and the Role of Skin Barrier Restoration Vanicream Moisturizing Skin Cream, Vanicream Cleansing Soap - Cutaneous Inflammation | Early Phase 1 | Terminated | University of Michigan | 14 | 2018-05-16 | 2021-05-06 |
| Revitalization of Damaged Skin Due to Chronic Skin Diseases ACE CSD - Chronic Eczema, Psoriasis | Early Phase 1 | Unknown | Ace Cells Lab Limited | 200 | 2018-05-01 | 2018-04-02 |
| Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis Fecal Microbial Transplantation - Atopic Dermatitis | Early Phase 1 | Completed | Tel-Aviv Sourasky Medical Center | 15 | 2017-11-01 | 2020-11-03 |
Showing 20 of 27. Sign in to see all of them.
Dermatitis, Atopic (12) · Psoriasis (3) · Radiodermatitis (3) · Blister (2) · Dermatitis, Seborrheic (2) · Eczema (2) · Asthma (1) · Breast Neoplasms (1) · Dermatitis, Allergic Contact (1) · Drug Hypersensitivity Syndrome (1) · Epidermolysis Bullosa (1) · Hand-Foot Syndrome (1) · Ichthyosis (1) · Intertrigo (1)
Skin Diseases (27) · Skin and Connective Tissue Diseases (27) · Skin Diseases, Eczematous (18) · Hypersensitivity (15) · Immune System Diseases (15) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Genetic Diseases, Inborn (12) · Hypersensitivity, Immediate (12) · Skin Diseases, Genetic (12) · Skin Diseases, Papulosquamous (5) · Skin Diseases, Vesiculobullous (4) · Chemically-Induced Disorders (3) · Drug Eruptions (3) · Drug Hypersensitivity (3)
Aminolevulinic Acid (1) · Caffeine (1) · Cyclosporine (1) · Diphenhydramine (1) · Drugs, Generic (1) · Ficusin (1) · Glutamine (1) · Itraconazole (1) · Melatonin (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Metoprolol (1) · Midazolam (1) · Omacor (1) · Omeprazole (1)
Mayo Clinic (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Ace Cells Lab Limited (1) · Amgen (1) · Brigham and Women's Hospital (1) · Centre Hospitalier Universitaire de Besancon (1) · Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan (1) · Dana-Farber Cancer Institute (1) · Emeishan Hospital of Traditional Chinese Medicine (1) · Hayat Abad Medical Complex, Peshawar (1) · HealOr (1) · Image Dermatology P.C. (1) · Janssen Research & Development, LLC (1) · Northwestern University (1) · Peking Union Medical College Hospital (1)
United States (13) · China (3) · Israel (2) · Pakistan (2) · Belgium (1) · France (1) · Germany (1) · Malaysia (1) · Serbia (1) · United Kingdom (1)
Amy Paller, MD (1) · Bruce D Levy, MD (1) · Donald Leung, MD, PhD (1) · Dr Fahad Khan (1) · Dr. Diana Diana, MSc Dermatology (1) · Elena Anna De Filippis, MD, PhD (1) · Gary Fisher, PhD (1) · Hongzhong Jin, MD (1) · Jacob Mashiah, MD (1) · Jeanine B. Downie, M.D. (1) · Jeffrey B Travers, MD, PhD (1) · Jennifer Huang, MD (1) · Joshua D Milner, M.D. (1) · Kylie Liermann, DO (1)
P01GM095467 (1)